1. Home
  2. LBTYA vs MMED Comparison

LBTYA vs MMED Comparison

Compare LBTYA & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Global Ltd.

LBTYA

Liberty Global Ltd.

HOLD

Current Price

$10.38

Market Cap

4.0B

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.92

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LBTYA
MMED
Founded
2004
1983
Country
Bermuda
United States
Employees
6636
2800
Industry
Cable & Other Pay Television Services
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.3B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
LBTYA
MMED
Price
$10.38
$16.92
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$13.72
$22.56
AVG Volume (30 Days)
2.1M
1.1M
Earning Date
05-01-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.41
$15.99
Revenue Next Year
$3.03
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.63
$10.65
52 Week High
$13.52
$17.86

Technical Indicators

Market Signals
Indicator
LBTYA
MMED
Relative Strength Index (RSI) 33.90 66.38
Support Level $10.38 $14.70
Resistance Level $11.56 N/A
Average True Range (ATR) 0.33 0.92
MACD -0.02 0.07
Stochastic Oscillator 3.73 89.16

Price Performance

Historical Comparison
LBTYA
MMED

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: